Skip to content

Clinical trials

Uterine Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Neoplasms Clear all

246 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20026
20038
20046
20054
200616
20072
20086
20093
20107
201110
20128
20134
20145
201510
20168
201710
201813
201917
202015
202112
20228
202314
202416
202517
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed114
Recruiting43
Unknown status29
Terminated25
Active, not recruiting14
Not yet recruiting9
Withdrawn8
No longer available1
Suspended1
Temporarily not available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center15
Memorial Sloan Kettering Cancer Center10
University of Alabama at Birmingham5
Dana-Farber Cancer Institute4
National Cancer Institute (NCI)4
Northwestern University4
University Health Network, Toronto4
Abramson Cancer Center at Penn Medicine3
Eli Lilly and Company3
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Neoplasms246
Ovarian Neoplasms106
Uterine Cervical Neoplasms100
Endometrial Neoplasms73
Breast Neoplasms42
Neoplasms37
Vulvar Neoplasms31
Urinary Bladder Neoplasms30
Vaginal Neoplasms29
Lung Neoplasms28

Trials

Showing 76 to 100 of 246. Each trial links to its page on Pharma Observatory.

146 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.